About Scientia Vascular
Scientia Vascular is a Healthcare company based in West Valley City (United States) founded in 2010 by John Lippert, and was acquired by Medtronic in March 2026. Vascular access supplies are manufactured for medical applications. Scientia Vascular has raised $64 million across 2 funding rounds from investors including Medtronic, Piper Sandler and Vivo Capital. The company has 171 employees. Its chief executive, as recorded, is John Lippert. Scientia Vascular offers products and services including Aristotle 14 Guidewire and Socrates 38 Microcatheter. Its focus areas include Traditional Medical Devices. Its legal entity is Scientia Vascular, Inc.
Company details
Scientia Vascular was founded in 2010 and is headquartered in West Valley City, United States. Operations are centered on the production of vascular access supplies within the medical device sector. These supplies support procedures related to vascular interventions. The company is led by founder and CEO John Lippert. Focus remains on manufacturing for healthcare providers across the region.
- Headquarters West Valley City, United States
- Employees 171
- Founders John Lippert
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website scientiavascular.com
- Social LinkedIn X
- Acquired by Medtronic (Mar 2026)
- Legal Name Scientia Vascular, Inc
Products & Services of Scientia Vascular
Scientia Vascular offers a comprehensive portfolio of products and services, including Aristotle 14 Guidewire and Socrates 38 Microcatheter.
Guidewires are developed for navigating neurovasculature with enhanced precision and flexibility through microfabrication techniques.
Catheters are created to maintain integrity and provide predictable advancement over guidewires for therapy delivery in distal areas.
Funding Insights of Scientia Vascular
Scientia Vascular has successfully raised a total of $64M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $14 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $64M
- Total Rounds 2
- Last Round Series C — $14M
- First Round $50M
(May 2021)
- Investors Count 2
All 2 funding rounds of Scientia Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $14M | Series C | – | Piper Sandler | – |
| May 2021 | $50M | Series C | – | Vivo Capital | – |
3 investors in total: 3 institutional.
Investors in Scientia Vascular
Scientia Vascular has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Piper Sandler and Vivo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
Advisory services for corporate mergers and acquisitions are provided. | 1895 | pipersandler.com | Minneapolis, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for Scientia Vascular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Scientia Vascular
7 people are tracked at Scientia Vascular (6 in leadership, 1 in team); the tracked headcount is 171.
| Name | Role | Group |
|---|---|---|
John Lippert | Founder & CEO | Leadership |
Amarinder Gill | Senior Director of Quality Assurance | Leadership |
Larry Myres | COO | Leadership |
Martha Ganesh | VP of Research & Development | Leadership |
Dan Housley | Senior Director Of Marketing | Leadership |
Anthony P. | National Director, Corporate Accounts | Leadership |
Ashley Ludack | Quality Engineer | Team |
Complete people profiles for Scientia Vascular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Scientia Vascular
4 dated milestones of Scientia Vascular across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Scientia Vascular is founded.
- Funding First funding round of $50.0M.
- Funding Latest funding round, Series C, of $14.0M.
- Exit Acquired by Medtronic.
Web traffic of Scientia Vascular
The website of Scientia Vascular (scientiavascular.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▼ 43.5% vs previous month
Websites whose visitors overlap most with Scientia Vascular. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| arrotek.com | 100% | 7.6K | #2,880,505 | View details |
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as Scientia Vascular (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 20.63 B | 53,000 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Scientia Vascular
Scientia Vascular was founded in 2010 and raised its 1st funding round 11 years after it was founded.
Scientia Vascular is headquartered in West Valley City, United States. It is registered at West Valley City, Utah, United States.
John Lippert is the CEO of Scientia Vascular, as recorded in our data. They have also founded this company.
Scientia Vascular is a funded company, having raised a total of $64M across 2 funding rounds to date. The company's 1st funding round was a Series C of $50M, raised on May 2021.
Scientia Vascular has 171 employees.
Scientia Vascular was founded in 2010 and is headquartered in West Valley City, United States. Operations are centered on the production of vascular access supplies within the medical device sector. These supplies support procedures related to vascular interventions. The company is led by founder and CEO John Lippert. Focus remains on manufacturing for healthcare providers across the region.
Scientia Vascular offers Aristotle 14 Guidewire and Socrates 38 Microcatheter.
Scientia Vascular has 3 investors. Key investors include Medtronic, Piper Sandler, and Vivo Capital.
Scientia Vascular operates through Scientia Vascular, Inc.
Yes. Scientia Vascular was acquired by Medtronic in March 2026.